There are two ways to test for mycotoxins in an indoor environment: collect what has settled over time, or sample what you are actively breathing. The RealTime Labs mycotoxin test (EMMA) collects settled dust. Respirare Labs AMEA samples the air you breathe. Both use ELISA to detect mycotoxins and both are marketed for indoor environmental investigation, but they are measuring fundamentally different things, and understanding that difference is the most important step before ordering any mycotoxin test.
This comparison breaks down how each test works, where each one falls short, and which approach is better aligned with the question most people are actually trying to answer: am I being exposed to mycotoxins? Air sampling answers that question. Dust sampling does not.
Air and Dust Do Not Answer the Same Question
AMEA measures airborne mycotoxins from the space you are actively breathing, while EMMA measures settled dust collected from surfaces over time.
What Is the RealTime Labs Mycotoxin Test (EMMA)?
EMMA stands for Environmental Mold and Mycotoxin Assessment. It’s a dust-collection-based test offered by RealTime Labs. Their primary recommended sample is a 3″x3″ cutout from an HVAC filter that has been in place for at least six weeks. Other recommended collection locations include the back of a refrigerator, under furniture, vents, and A/C returns, places specifically chosen because dust has been accumulating there undisturbed, potentially for months or years. Their sampling instructions also list an unused Swiffer duster as a valid option, though their own FAQ discourages it, citing potential chemical interference with results.
The collected material is analyzed using ELISA for mycotoxin detection and MSQPCR for mold species identification.
The underlying logic is that mycotoxins settle out of the air over time and accumulate in dust, so testing that settled dust should give you a picture of mycotoxin presence in the home’s air.
There are several meaningful limitations to this approach.
No standardized collection volume
The amount of dust on any given swab varies based on how long it’s been since the area was last cleaned, the activity level in the home, and the surface material. Without knowing how much dust was collected, concentration results can’t be reliably compared between samples or across homes.
No defined sampling standard
Unlike air sampling, which has established industrial hygiene protocols specifying pump flow rates, cassette types, and sample durations, EMMA lacks a strict standardized protocol. This introduces variability in how results are collected and what they represent.
Post-remediation clearance is ambiguous
If remediation has been performed correctly, there may be no accumulated dust to swab. RealTime Labs acknowledges this by suggesting additional dust samples post-remediation, but this raises an immediate practical problem: how long should an IEP wait for dust to accumulate before testing? And how can a family safely reoccupy a home without a clear, protocol-based clearance benchmark?
Dust does not reflect current air quality
Mycotoxins detected in settled dust represent what has accumulated over time, potentially months or years, and not what is currently circulating in the breathing zone. These are analytically distinct sampling domains, and interpreting dust results as a proxy for air exposure is not scientifically supported.
What Is the Respirare Labs AMEA?
AMEA stands for Airborne Mycotoxin Environmental Analysis. Where EMMA collects what has settled, AMEA captures what you are actively breathing. It draws a direct air sample from the breathing zone using a calibrated IOM (Institute of Occupational Medicine) sampler paired with an A.P. Buck Libra L-4 pump. These are the same industrial hygiene standards used in occupational safety and environmental health investigations, fields where the accuracy of air sampling has been validated over decades. This isn’t consumer-grade equipment — it’s the methodology used when exposure actually needs to be measured.
Each sample runs for a standardized one hour at a fixed rate of 2 liters per minute, a flow rate specifically designed to replicate the average human inhalation rate. This means the sample isn’t just a measurement of what’s in the air. It’s a direct representation of what a person would actually breathe during that hour in that space. Because the volume is known and fixed, results can also be compared meaningfully between rooms, between properties, and over time.
Direct Air Sampling Matters
A calibrated breathing-zone air sample provides a measurable, consistent foundation for evaluating airborne mycotoxin exposure.
The collected sample goes through a patented extraction process before being analyzed using certified ELISA kits. Because ELISA is the same analytical method used in EMMA, the difference between the two tests is not the lab chemistry. It’s what you’re actually sampling.
One of the most clinically meaningful features of AMEA is that results are interpreted against established background levels derived from homes with no known history of water damage, fungal infestation, or mycotoxin-related illness. This matters because a mycotoxin result without a reference point is just a number. AMEA results tell you not just what was detected, but whether what was detected is elevated relative to what is typically found in unaffected homes. That context is what makes the result actionable for IEPs, healthcare professionals, and homeowners alike.
For a deeper look at how AMEA sampling maps to inhalation exposure, see the Inhalation-Aligned Airborne Mycotoxin Assessment preprint and its accompanying interpretive guide.
Why the Mycotoxin Sample Type Matters
Mycotoxin exposure happens through inhalation. That’s not a matter of interpretation. It’s how the body encounters airborne toxins. So the best method to answer the exposure question is one that samples what you are actually breathing. Everything else is measuring a proxy.
When someone asks “am I being exposed to mycotoxins in my home?” the question is about inhalation. The relevant domain is the breathing zone. Air sampling is aligned with that question. Dust sampling is not.
Respirare Labs’ research has examined this gap in detail. Our published preprint on physicochemical divergence of mycotoxin indicators establishes that mycotoxins in settled dust and mycotoxins in actively circulating air behave differently, partition differently, and are not interchangeable as exposure indicators.
The interpretive guide “How to Interpret Mold Test Results and Mycotoxins” translates this research into practical guidance, including what it means when results differ between air, dust, and surface samples.
The practical takeaway: a positive EMMA result tells you mycotoxins have been present at some point. An AMEA result tells you what’s in the air you’re breathing today.
Which Mycotoxin Test Best Represents Indoor Exposure?
This isn’t a matter of opinion. It’s a question of what each test is designed to measure.
If you want to know whether mycotoxins are currently present in the inhalable air of a space, you need air sampling. Settled dust is a historical reservoir that accumulates over time and reflects past activity, not current conditions. Dust that has been accumulating undisturbed for weeks or months in a filter or vent is not representative of what a person is actively inhaling during daily activity.
The reason dust and air are not interchangeable comes down to physics and particle behavior. Mycotoxins in indoor environments tend to associate with fine and ultrafine particles, some smaller than 1 micron in diameter. Particles this small do not settle readily. They remain suspended in the breathing zone, move easily with normal airflow and everyday activity, and can penetrate deep into the lower respiratory tract upon inhalation (Brasel et al., 2005; Andersen et al., 2017). Settled dust, by contrast, is dominated by larger, heavier particles that have already dropped out of the air. These are not the same particles that a person is inhaling.
There is also a phase transition argument. Once a particle settles from air into a dust reservoir, it has moved from a dynamic airborne environment into a static, surface-bound state. The presence of a mycotoxin in settled dust confirms it has been in the home at some point. It does not establish whether that compound is currently suspended in the air you are breathing (Ritacco, 2026b). As Respirare Labs’ foundational preprint on physicochemical divergence of mycotoxin indicators establishes, mycotoxins in settled dust and mycotoxins in actively circulating air behave differently, partition differently, and cannot be used as proxies for one another.
The practical consequence is straightforward: a dust test can tell you mycotoxins have been present. An air test tells you whether they are present now, at concentrations relevant to what you are breathing today.
Our research preprint “Exposure-Aligned Mycotoxin Domain Interpretation” addresses this directly, establishing a framework for aligning test methodology with the exposure question being asked.
The companion interpretive guide “Which Mycotoxin Test Best Represents Indoor Exposure?” translates this framework into practical guidance for IEPs and homeowners trying to determine which test belongs in a given investigative scenario.
For a broader overview of the testing landscape, Environmental Mycotoxin Testing: Air vs. Dust Results covers these distinctions in accessible terms.
Side-by-Side Comparison
| Factor | RealTime Labs EMMA | Respirare Labs AMEA |
|---|---|---|
| Sample Type | HVAC filter cutout or dust swab | Active air sample (IOM cassette) |
| Collection Standard | ✖ No standardized protocol | ✔ 1-hour sample at 2L/min (fixed) |
| Sample Volume Known? | ✖ No | ✔ Yes |
| Exposure Domain | Dust reservoir (historical) | Breathing zone (current) |
| Analytical Method | ELISA (mycotoxins) + MSQPCR (mold species) | ELISA + patented extraction |
| Background Reference Levels | ✖ No | ✔ Yes |
| Post-Remediation Protocol | ✖ Not defined | ✔ Defined clearance protocol |
| Domain-Aligned for Inhalation Exposure | ✖ No | ✔ Yes |
| Price | Contact RealTime Labs | View current pricing → |
Which Mycotoxin Test Is Right for Your Situation?
The answer depends on what question you are trying to answer.
If the question is whether mycotoxins have been present in a home at some point, dust-based testing can provide that information. It is a legitimate method for that specific purpose.
If the question is whether you are currently being exposed to mycotoxins through the air you breathe, dust-based testing cannot answer it. The only way to answer that question is to sample what you are actually breathing. That is what AMEA does.
For homeowners, patients, healthcare professionals, and IEPs whose primary concern is inhalation exposure, air sampling is the exposure-aligned choice. It measures what is present in the breathing zone at the time of testing, using a standardized method with defined reference levels and a clear post-remediation protocol.
For guidance on choosing between air, dust, and surface testing based on your specific situation, the guide How to Choose the Right Mycotoxin Test at Home is a practical starting point.
Two Mycotoxin Tests, Two Different Questions
The RealTime Labs mycotoxin test (EMMA) collects settled dust. Respirare Labs AMEA samples the air you breathe. That difference in sample type is the difference between a historical record and a current exposure measurement. Both tests use ELISA, but the chemistry is only as meaningful as what you are actually sampling.
For questions about inhalation exposure, which is the relevant question in the vast majority of health-driven indoor investigations, AMEA is the domain-aligned choice.
Ready to test what you're actually breathing?
Frequently Asked Questions
EMMA uses ELISA, which is a validated method for mycotoxin detection. The limitation is the sample collection itself. Because dust volume per swab is unknown and unstandardized, results are difficult to interpret as a measure of current inhalation exposure. EMMA may provide useful information for historical presence screening, but for assessing what someone is currently breathing, air sampling is more appropriate.
Not directly. Settled dust reflects what has accumulated over time, not what is currently airborne. If air quality and inhalation exposure are the primary concern, an air-based test like AMEA is better aligned with that question.
RealTime Labs recommends sending additional dust samples after remediation, but there is no defined protocol specifying when to collect them, how much dust is needed, or what concentration constitutes clearance. AMEA has an established post-remediation protocol with standardized collection and reference-level benchmarks.
AMEA kits can be ordered directly from Respirare Labs for DIY home use, or administered by a trained IEP. You can browse our testing options here, or find a Respirare Labs provider near you.
Surface testing using Respirare Labs' MESA kit is designed to assess mycotoxin contamination on materials and contents such as walls, flooring, furniture, and HVAC components. For most health-driven investigations, AMEA (air) is the primary tool and MESA is used to identify affected materials. Learn more about MESA mycotoxin surface testing here.
References
- Ritacco, J. (2026a). Physicochemical Divergence of Mycotoxin Indicators Across Environmental Sampling Domains. Respirare Labs. View preprint
- Ritacco, J. (2026b). Exposure-Aligned Mycotoxin Domain Interpretation. Respirare Labs. View preprint
- Ritacco, J. (2026c). Inhalation-Aligned Airborne Mycotoxin Assessment. Respirare Labs. View preprint
- Brasel, T.L., Martin, J.M., Carriker, C.G., Wilson, S.C., & Straus, D.C. (2005). Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins in the indoor environment. Applied and Environmental Microbiology, 71(11), 7376–7388. PubMed
- Andersen, B., Nielsen, K.F., Jarvis, B.B. (2017). Aerosolization of mycotoxins after growth of toxinogenic fungi on wallpaper. Applied and Environmental Microbiology. PMC
- RealTime Labs. Standard EMMA Inspector Collection Instructions. realtimelab.com Accessed March 18, 2026.
- RealTime Labs. EMMA Frequently Asked Questions. realtimelab.com/frequently-asked-questions Accessed March 18, 2026.
- World Health Organization. (2018). Mycotoxins. who.int Accessed March 18, 2026.
Respirare Labs provides environmental mycotoxin testing only. Results are informational and are not intended to diagnose, treat, cure, mitigate, or prevent any disease or health condition. Consult qualified medical and environmental professionals for personalized guidance.
